they bought a drug called tenactin.rt of that transaction, questcore was required to file with the fda for approval of tenactin in the u.s. mallinckrodt hasn't made any effort to get the company approved in the u.s. another company turned around and sued questcore, alleging antitrust violations. the lawsuit caught the attention of the ftc, the federal trade commission, which then launched a full investigation into whether questcore was engaging in anticompetitive behavior. and because mallinckrodt bought questcore, they're potentially on the hook for all of this. how about another red flag? holy cow. mallinckrodt's general counsel just right hand from the company not that long ago in the midst of the litigation. they haven't named a permanent replacement. we don't normally care about the general counsel except when the company is involved in important high profile litigation. that's what mallinckrodt is. one last thing. at a time when all the rollups are under pressure, again, i mentioned valiant as the one everyone is